Financial Ratios

PRISM MEDICO AND PHARMACY LTD.

NSE : NABSE : 512217ISIN CODE : INE730E01016Industry : Finance - InvestmentHouse : Private
BSE27.281.14 (+4.36 %)
PREV CLOSE ( ) 26.14
OPEN PRICE ( ) 26.14
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12625
TODAY'S LOW / HIGH ( )25.30 27.80
52 WK LOW / HIGH ( ) 22.0539.2
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.13-0.61-0.21-0.080.61
   CEPS(Rs)-0.12-0.60-0.19-0.050.65
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)25.0020.7121.3221.5321.69
   Tax Rate(%)25.3125.8625.8026.22-25.99
Margin Ratios
   Core EBITDA Margin(%)-7.64-5.80-0.97-0.190.28
   EBIT Margin(%)-8.03-5.90-1.04-0.250.81
   Pre Tax Margin(%)-8.05-5.91-1.05-0.250.81
   PAT Margin (%)-6.01-4.38-0.78-0.191.02
   Cash Profit Margin (%)-5.50-4.28-0.70-0.121.09
Performance Ratios
   ROA(%)-0.55-2.18-0.60-0.262.47
   ROE(%)-0.55-2.90-1.00-0.382.85
   ROCE(%)-0.74-3.91-1.35-0.522.26
   Asset Turnover(x)0.090.500.781.402.43
   Sales/Fixed Asset(x)30.1663.6476.22122.27165.11
   Working Capital/Sales(x)0.090.691.542.4411.83
Efficiency Ratios
   Fixed Capital/Sales(x)0.030.020.010.010.01
   Receivable days1384.89397.56346.74149.9537.78
   Inventory Days1945.06251.0953.286.859.28
   Payable days0.00178.61184.9582.4118.50
Valuation Parameters
   PER(x)0.000.000.000.0060.73
   PCE(x)-248.64-12.79-60.06-231.3056.63
   Price/Book(x)1.140.370.550.581.71
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)13.590.540.420.280.61
   EV/Core EBITDA(x)-180.98-9.32-42.94-148.0169.71
   EV/EBIT(x)-169.27-9.16-39.89-109.5876.05
   EV/CE(x)1.140.370.320.341.31
   M Cap / Sales13.660.550.420.280.62
Growth Ratio
   Net Sales Growth(%)-84.95-49.63-37.66-25.9373.23
   Core EBITDA Growth(%)80.52-201.30-223.51-115.70250.12
   EBIT Growth(%)79.54-184.90-157.80-123.13526.61
   PAT Growth(%)79.34-184.50-158.70-113.602053.23
   EPS Growth(%)79.34-184.52-158.68-113.602053.23
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)65.34708.222.262.291.80
   Quick Ratio(x)36.12319.611.702.291.55
   Interest Cover(x)-313.44-1083.14-709.78-272.121296.17
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.